Drawing for IMMUNITION

USPTO serial 86876521

IMMUNITION

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
MAYER, DAVID COREY
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IMMUNITION?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

THOMAS M. PALISI

THOMAS M. PALISI LERNER, DAVID, LITTENBERG, KRUMHOLZ & MENTLIK, LLP600 SOUTH AVENUE WESTWESTFIELD, NJ 07090UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
042PHARMACEUTICAL AND MEDICAL RESEARCH AND DEVELOPMENT; SCIENTIFIC AND TECHNOLOGICAL SERVICES, NAMELY, SCIENTIFIC RESEARCH, DEVELOPMENT, ENGINEERING, TESTING, SCIENTIFIC RESEARCH CONSULTATION, AND NON-DIAGNOSTIC ANALYTICAL SERVICES IN THE FIELDS OF MEDICINE, ONCOLOGY, HEMATOLOGY, AUTO-IMMUNE DISORDERS, INFECTIOUS DISEASES, IMMUNOLOGY, IMMUNOTHERAPIES, IMMUNOPHARMACEUTICALS, IMMUNE SEQUENCING, IMMUNE REPERTOIRE QUANTITATION AND SEQUENCING, MEDICAL DIAGNOSTICS, PHARMACEUTICALS, GENETICS, GENE EXPRESSION, GENETICS TESTING, VACCINES AND VACCINE DEVELOPMENT, BIOTECHNOLOGY, T-CELL THERAPEUTICS, ANTIBODY DEVELOPMENT AND THERAPEUTICS, AND THERAPEUTIC TECHNOLOGIESACTIVE—
044MEDICAL SERVICES; MEDICAL SERVICES, NAMELY, MEDICAL ANALYSIS AND DIAGNOSTIC SERVICES; MEDICAL DIAGNOSTIC SERVICES, NAMELY, MEDICAL TESTING FOR DIAGNOSTIC OR TREATMENT PURPOSES; MEDICAL DIAGNOSTIC SERVICES, NAMELY, MEDICAL DIAGNOSTIC TESTING, MONITORING AND REPORTING SERVICES; PROVIDING MEDICAL DIAGNOSTIC TESTING FOR THE TREATMENT OF CANCER; PROVIDING MEDICAL TESTING FOR IMMUNE RESPONSES TO IMMUNOTHERAPY OR CANCER TREATMENT; MEDICAL TESTING FOR DIAGNOSTIC OR TREATMENT PURPOSES, NAMELY, FOR IDENTIFYING NEOEPITOPES FOR THERAPEUTIC USEACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Mar 5, 2018MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 5, 2018ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 3, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 1, 2017EX2GSOU EXTENSION 2 GRANTED—
Aug 1, 2017EXT2SOU EXTENSION 2 FILED—
Aug 1, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 26, 2017EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jan 24, 2017EX1GSOU EXTENSION 1 GRANTED—
Jan 24, 2017EXT1SOU EXTENSION 1 FILED—
Jan 24, 2017EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Aug 2, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 7, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 7, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 18, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
May 3, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 2, 2016DOCKASSIGNED TO EXAMINER—
Jan 20, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 19, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance